Ian Ford

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Karl Swedberg, Michel Komajda, Michael Böhm et al. · The Lancet · 2010 · 2.6K citations · Full text

Medicine, Cardiology, Pharmacology +11

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management

Steen Dalby Kristensen, Juhani Knuuti, Antti Saraste et al. · European Heart Journal · 2014 · 1.7K citations

Medicine, Cardiology, Surgery +17

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

Michael Böhm, Karl Swedberg, Michel Komajda et al. · The Lancet · 2010 · 1.1K citations

Medicine, Cardiology, Clinical Cardiology +13

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Kim Fox, Ian Ford, Philippe Gabríel Steg et al. · The Lancet · 2008 · 1.1K citations · Full text

Medicine, Cardiology, Pharmacology +14

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

Kim Fox, Ian Ford, Philippe Gabríel Steg et al. · The Lancet · 2008 · 788 citations

Medicine, Cardiology, Internal Medicine +15